A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes
Status:
Withdrawn
Trial end date:
2022-06-06
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate a novel approach for insulin glargine
(LY2963016) titration for insulin-naïve adults with type 2 diabetes (T2D)
The study will last about 6 months.